Avandia (also known as rosiglitazone) is used for treatment of Type 2 diabetes. This drug is used nationwide by more than 50,000 individuals. Unfortunately, there are several risks associated with the use of the drug, with one of the most prominent being an increased risk of heart attack.
If you or a loved one has suffered from the use of this drug, our experienced Avandia drug injury lawyers will advocate for your interests and hold GlaxoSmithKline, the manufacturer, accountable for promoting this unsafe drug. We are the attorneys at Aaron M. Levine & Associates, and we represent individuals in Pennsylvania, Virginia, Maryland, California, Texas, Massachusetts, New York, Illinois, Florida, Washington and nationwide in defective drug and defective medical device cases.
Cardiovascular Events and the Use of Avandia
In 2007, GlaxoSmithKline (GSK) changed the labeling on Avandia (generic form is rosiglitazone), warning Avandia users of the risks associated with the drug. GSK warned only after the U.S. Food and Drug Administration (FDA) determined that heart attacks could be linked to the use of the drug. Since 2007 there have been several lawsuits filed against GSK, which continue to be ongoing. GlaxoSmithKline should be held accountable for promoting this drug and failing to inform Avandia users of the increased risks of cardiovascular events such as heart attacks, strokes, pulmonary embolisms and deep vein thrombosis (DVT).
Over the past 50 years our law firm has been committed to holding pharmaceutical companies liable for promoting unsafe drugs. Our team of legal and medical professionals has a reputation within the legal community for providing high-quality and comprehensive legal services.
Contact Our Nationwide Drug Defects Litigation Attorneys
Learn about the legal services our lawyers provide and how we can help protect your interests. We invite you to contact our firm at 202-559-0393 or 888-564-9305 to schedule a consultation. You will receive the individualized attention your situation deserves.
